Clinical Research Directory
Browse clinical research sites, groups, and studies.
Re-ablation of Persistent Atrial Fibrillation
Sponsor: Aarhus University Hospital
Summary
Pulmonary vein re-isolation plus Vein of Marshall ethanol ablation in combination with block of mitral and tricuspid isthmuses and dome line will be compared to pulmonary vein re-isolation alone in patients undergoing re-ablation for persistent atrial fibrillation in this investigator initiated, randomized, patient-assessor blinded multicenter trial. Patients are followed with standard ECG at 3 months, with standard ECG, 5-days' ECG monitoring and quality of life assessment after 12 months, with standard ECG and quality of life assessment after 24 months, through patient files at 60 months after the ablation. Primary endpoint: Change in AFEQT score between baseline and 12 months.
Official title: Re-ablation of Persistent Atrial Fibrillation: a Randomized Study, Evaluating Vein of Marshall Ethanol Ablation in Combination With Block of Mitral and Tricuspid Isthmuses and Dome Line
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
180
Start Date
2025-03
Completion Date
2032-10
Last Updated
2025-02-28
Healthy Volunteers
No
Conditions
Interventions
Intervention
pulmonary vein re-isolation plus Vein of Marshall ethanol ablation in combination with block of mitral and tricuspid isthmuses and dome line
Control
pulmonary vein re-isolation
Locations (3)
Department of Cardiology, Aarhus University Hospital
Århus N, Danmark, Denmark
Department of Cardiology, Leiden University Medical Center
Leiden, Netherlands
Department of Cardiology, Karolinska University Hospital, Stockholm
Stockholm, Sweden